Get an alert when IQVIA INVESTMENT HOLDINGS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-07-28 (in 2mo)

Last made up 2025-07-14

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£262M

+3.7% vs 2023

Employees

0

Average over period

Profit before tax

£10M

-39.4% vs 2023

Name history

Renamed 1 time since incorporation

  1. IQVIA INVESTMENT HOLDINGS LIMITED 2019-06-03 → present
  2. FORESIGHT GROUP INTERNATIONAL UK LTD 2017-01-26 → 2019-06-03

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover
Operating profit
Profit before tax £17,056,975£10,335,467
Net profit £15,925,629£9,337,236
Cash
Total assets less current liabilities £253,391,175£263,584,568
Net assets £252,665,580£262,002,816
Equity £252,665,580£262,002,816
Average employees 00
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Forvis Mazars LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have reviewed the financial position of the company. The directors note that the company is in a net assets position at 31 December 2024. The directors have considered the company’s cash requirements for 12 months after the date of signing these financial statements and as a result have adopted the going concern basis of accounting. As such, these financial statements have been prepared on the going concern basis.”

Group structure

  1. IQVIA INVESTMENT HOLDINGS LIMITED · parent
    1. IQVIA RDS GmbH 100% · Germany · Clinical Research
    2. IQVIA Clinical AB 100% · Sweden · Clinical Research
    3. IQVIA RDS Italy S.r.l. 100% · Italy · Clinical Research
    4. IQVIA RDS France SAS 100% · France · Clinical Research
    5. IQVIA Clinical, Filial af IQVIA Clinical AB 100% · Denmark · Clinical Research
    6. IQVIA RDS Norway 100% · Norway · Clinical Research
    7. Quintiles Norway 100% · Norway · Clinical Research
    8. IQVIA RDS Netherlands B.V. 100% · Netherlands · Clinical Research
    9. Belongtail Ltd 17.54% · Israel · Technology Services
    10. ClinTec International Off-Shore S.A.L. 0.5% · Lebanon · Clinical Research

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 5 resigned

Name Role Appointed Born Nationality
JTC (UK) LIMITED Corporate Secretary 2023-06-21
MECCI, Imran Director 2019-04-08 Apr 1977 British
SANTOS, Carlos Director 2019-05-31 Dec 1981 British
TURLAND, Kevin John Director 2020-08-14 Mar 1969 British
Show 5 resigned officers
Name Role Appointed Resigned
HALCO SECRETARIES LIMITED Corporate Secretary 2019-04-16 2023-06-21
TMF CORPORATE ADMINISTRATION SERVICES LIMITED Corporate Secretary 2017-01-26 2019-04-01
DOSANJH, Updesh Singh Director 2017-01-26 2017-07-18
MACDONALD, Alasdair Director 2017-07-18 2019-04-16
RYMSZA, Joseph Matthew Director 2017-01-26 2017-07-18

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Iqvia Ltd. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2017-07-18 Active

Filing timeline

Last 20 of 49 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2022-06-08 RESOLUTIONS Resolution
Date Type Category Description
2025-07-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-04 AA accounts Accounts with accounts type full
2024-07-16 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-10 AA accounts Accounts with accounts type full
2023-11-06 CH01 officers Change person director company with change date PDF
2023-10-09 AD02 address Change sail address company with old address new address PDF
2023-10-06 AP04 officers Appoint corporate secretary company with name date PDF
2023-10-06 TM02 officers Termination secretary company with name termination date PDF
2023-07-20 CH01 officers Change person director company with change date PDF
2023-07-20 CH01 officers Change person director company with change date PDF
2023-07-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-15 AA accounts Accounts with accounts type full
2022-07-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-07-05 AA accounts Accounts with accounts type full
2022-06-08 SH19 capital Capital statement capital company with date currency figure
2022-06-08 SH20 capital Legacy
2022-06-08 CAP-SS insolvency Legacy
2022-06-08 RESOLUTIONS resolution Resolution
2021-10-03 AA accounts Accounts with accounts type full
2021-09-01 AD01 address Change registered office address company with date old address new address PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page